Skip to product information
1 of 1

  • Gphc Registered
  • Join over 100k customers
  • Fixed prices and no subscriptions
  • Discreet next day delivery.
  • Free shipping on all orders over £50

Canesten Thrush Internal Cream - 5g

Canesten Thrush Internal Cream - 5g

  • Ozempic®️-equivalent therapy now available for weight management
  • Average weight loss of 17%, with 1 in 3 patients achieving over 20%
  • May help reduce osteoarthritis-related pain
  • Wegovy®️ is not expected to impact the effectiveness of oral contraceptives
  • Supports cardiovascular risk reduction
  • Over 22 million patients treated with semaglutide-based therapies since 2018

We’re proud to offer fast and discreet delivery for all our medicines & treatments.

Price Checker

Regular price £8.99
Sale price £8.99
Sale Sold out
  • Lowest price guarantee
  • Includes FREE private prescription
View full details

The vaginal thrush internal cream from Canesten provides quick targeted pain relief. The 5g pre-filled applicator functions as a single-dose treatment to address vaginal thrush at its internal origin.

The internal cream contains clotrimazole 10% w/w as its active antifungal ingredient which fights infection while providing relief from itching and abnormal discharge and vaginal irritation. The pre-filled applicator allows users to insert the cream directly into their vagina for a simple one-dose treatment.

Key Benefits:

  • Single-dose internal treatment for vaginal thrush
  • Contains clotrimazole 10% –  a proven antifungal
  • Pre-filled applicator for easy and hygienic use
  • Relieves  internal discomfort and clears infection
  • Suitable for use at bedtime for optimal results

How to Use:

Use the entire content of the pre-filled applicator by inserting it into the vagina during nighttime for maximum effectiveness. Read the leaflet before starting the treatment.

Suitable For:

The product is designed for women aged 16 to 60 who have received previous thrush diagnoses. Consult your doctor before using this product during pregnancy.

Patient Information Leaflet

Important - Before taking any medication, it is always important to read the Patient Information Leaflet (PIL)

Written and reviewed by our qualified team

GPhC Number: 2088658
Muzammil Peerally

Authored by:

Muzammil Peerally

Superintendent Pharmacist

GPhC Number: 2232689
Tarun Kumar

Reviewed by:

Tarun Kumar

Clinical Leads

📖 Find out more about our team of medical content authors and how we ensure the accuracy of our content with our content guidelines.

Content last updated: 31 Mar 2025

We’re a safe and
regulated UK service

Registered Pharmacy Badge

Lowest Price Guarantee

We're convinced you won't find your treatment cheaper, but if you do we'll refund the difference.

Find out more

100% discreet packaging

We're convinced you won't find your treatment cheaper, but if you do we'll refund the difference.

Find out more

Agent

Need help?
Talk to our friendly experts now

How our service works

Service Setup

Service setup

Discreet Packaging

Discreet packaging

Express Delivery

Express delivery

Comparison of Weight Loss Injectables

Features

Mounjaro®

Injectable Pen

Wegovy®

Injectable Pen

Saxenda®

Injectable Pen

Active Ingredient Tirzepatide Semaglutide Liraglutide
Mechanism of Action GLP-1 and GIP receptor agonist GLP-1 receptor agonist GLP-1 receptor agonist
Administration Weekly injection Weekly injection Daily injection
Dosage Varies by patient, typically starting low Varies, typically starting at 0.25 mg Varies, starting at 0.6 mg
Effect on Appetite Significantly reduces appetite and cravings Reduces appetite and increases satiety Reduces appetite and increases satiety
Average Weight Loss Up to 20% body weight reduction Up to 15% body weight reduction Significant weight reduction
Side Effects Nausea, vomiting, diarrhoea, constipation Nausea, vomiting, diarrhoea, constipation Nausea, diarrhoea, constipation, hypoglycemia
Approval FDA-approved for weight loss FDA-approved for weight loss FDA-approved for weight loss
Suitable For Adults with BMI ≥30 or ≥27 with comorbidities Adults with BMI ≥30 or ≥27 with comorbidities Adults with BMI ≥30 or ≥27 with comorbidities